Self-Assessment Post-Test

SELF-ASSESSMENT POST-TEST Complete the following by circling the correct answer below. The Clinical Management of Interstitial Cystitis 1. Which of the following is not commonly associated with interstitial cystitis (IC)? a. Multiple allergies b. Fibromyalgia c. Inflammatory bowel disease d. Pyelonephritis 10. The most commonly used antihistamine in the treatment of IC is: a. Hydroxyzine hydrochloride b. Diphenhydramine hydrochloride c. Cetirizine hydrochloride d. Loratadine 2. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) criteria: a. Remain the gold standard for diagnosis of IC b. Underestimate the true incidence of IC c. Can be used for both research and clinical evaluation d. Were utilized to screen patients for entry into the Interstitial Cystitis Data Base Study 11. The patient most likely to respond to pentosan polysulfate: a. Has had IC for over 10 years b. Takes pentosan polysulfate continuously for 6 months c. Has severe glomerulations d. Has previously responded to dimethyl sulfoxide 3. Which of the following is not a potential marker for IC? a. Leucocyte esterase b. Interleukin 2 (IL-2) c. Antiproliferative factor (APF) d. Glycoprotein 51 (GP-51) 4. Which of the following is not considered to be a potential etiology for IC? a. Neurogenic inflammation b. Mast cell activation c. Congenital spinal cord defect d. Sensor nerve stimulation e. Autoimmune phenomenon 5. 6. 7. 8. 9. Glomerulations: a. Must be present to make a diagnosis of IC b. Are never seen in normal patients c. Provide helpful prognostic information d. Are commonly seen in IC patients but are not pathognomonic Which of the following patients should be evaluated for IC? a. Overactive bladder patients unresponsive to anticholinergics b. Patients with unexplained pelvic pain c. Patients with chronic prostatitis unresponsive to antibiotics d. All of the above When developing a multimodality treatment strategy, which of the following is not recommended? a. Hormonal manipulation b. Antihistamines c. Heparinoids d. Antidepressants Which of the following is not true of tricyclic antidepressants? a. Antihistamine activity b. Helpful in pain management c. Direct antibacterial activity d. Sleep aid e. Anticholinergic effect Which of the following is incorrect? a. It may take 6–9 months of continuous therapy with pentosan polysulfate before symptoms start to improve b. Pentosan polysulfate commonly causes bleeding dysfunction c. Pentosan polysulfate may cause GI upset d. Pentosan polysulfate can be taken in conjunction with other therapies 12. Which of the following is not helpful in managing IC? a. Prelief b. Increased fluid intake c. Urinary alkalinazation d. Elimination of dietary irritants e. Cranberry juice 13. Natural mucopolysaccharides include all but: a. Aloe vera b. Chondroitin sulfate c. Hyaluronic acid d. Quercitin 14. Pelvic floor rehabilitation includes: a. Biofeedback b. Electrical stimulation c. Physical therapy of outer and inner pelvis d. Thiele massage e. All of the above 15. Transforaminal neurostimulation: a. Is approved for treatment of IC b. Is approved for treatment of urgency, urge incontinence, and retention c. Is appropriate for all patients with pelvic pain d. Does not require testing prior to implantation 16. Which of the following does not indicate placement of the neurostimulator in the S3 foramen? a. External rotation of the foot b. Bellows effect c. Great toe dorsiflexion d. Tapping sensation in rectum or vagina 17 Potassium sensitivity test (PST): a. Demonstrates uroepithelial dysfunction b. Is positive in 80% of IC patients c. Is positive in 55% of urethral syndrome patients d. Is positive in a majority of patients with pelvic pain e. All of the above 18. Which of the following is false? a. Patients with normal epithelium do not respond to PST b. Urothelial injury with protamine causes a positive PST c. Intravesical heparin can reverse urothelial injury d. Sodium chloride will provoke urgency similar to potassium chloride VOL. 4 SUPPL. 1 2002 REVIEWS IN UROLOGY S57 REGISTRATION The Clinical Management of Interstitial Cystitis Name Title Address City State Zip Fax E-Mail Specialty Phone COURSE EVALUATION Using a five-point scale (5 = strongly agree; 4 = agree; 3 = uncertain; 2 = disagree; 1 = strongly disagree), please answer the following evaluation questions. __ __ __ __ __ The content seemed current. The program content was relative to my practice. Overall, the supplement provided a valuable learning experience. My personal objectives in reading this supplement were fulfilled. The supplement was presented as a fair and balanced discussion and was not commercial in nature. The Institute for Medical EducationSM designates this educational activity for a maximum of 3 hours in Category 1 credit toward the AMA Physician’s Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity. Signature Credit Hours (not to exceed 3 hours) I would be interested in attending a CME program on this topic in my area. Mail To: The Institute for Medical EducationSM 100 UCLA Medical Plaza Suite 690 Los Angeles, CA 90095 Or Fax To: 310.824.0298 Additional Comments: Release Date: February 28, 2002 Expiration: Credit will be awarded for required materials postmarked or received no later than February 28, 2003. Certificates will be mailed within one month of receipt of these materials. S58 VOL. 4 SUPPL. 1 2001 REVIEWS IN UROLOGY